Josep Bassaganya-Riera to deliver TED talk on November 10th
BLACKSBURG, VA., October 3, 2016 – This is the fifth year ofthe TEDx series at Virginia Tech. Featured speakers will focus their talks upon the theme of “Spark,” as in the moment of inspiration that sets one on a new journey.
How many of us have shunned medication because, “the treatment is worse than the disease”? How many of us have experienced anti-inflammatory treatments with limited efficacy and significant side effects? Breakthroughs in precision medication may soon change the attitudes – and the experiences – of those of us suffering from inflammatory diseases.
Josep Bassaganya-Riera, Director of the Nutritional Immunology and Molecular Medicine Laboratory (NIMML) at Virginia Tech and Founder of BioTherapeutics will outline the future of precision medicine for inflammatory diseases on November 10, 2016, presenting the talk, Accelerated Path to Cures.
The NIMML team at Virginia Tech is at the forefront of research efforts designed to understand how immune system behavior in health and disease emerges from molecular, genetic, cellular, microbial and dietary modulatory elements.
Bassaganya-Riera will bring attention to transformative modeling approaches developed at Virginia Tech that have been found to improve efficiency, decrease cost and reduce the time required to find treatments for debilitating and widespread diseases. These modeling approaches combine computational and experimental methods. As a result, the identification, evaluation, and selection of drug targets and leads become less trial and error and more targeted, and better-informed development paths to new therapeutics and nutritionals.
The event will be hosted at the Moss Arts Center on the Virginia Tech campus and streamed live online. For more information on the event as a whole, please visit TEDx Virginia Tech.